Head and Neck Neoplasm — Trials

Head and Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,372 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 101–150 of 2,192 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01810913	Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer	suspended	Phase 2 / Phase 3	613	National Cancer Institute (NCI)NIH	3	Sep 1, 2026	clinicaltrials
NCT05054439	A Clinical Study of SI-B001 in Combination With Paclitaxel/Docetaxel in the Treatment of Recurrent and Metastatic HNSCC	active not recruiting	Phase 2	45	Sichuan Baili Pharmaceutical Co., Ltd.INDUSTRY	1